U.S. Roche 401(k) Savings Plan
Active. The plan filed its annual report for the 2024 plan year.
- Plan number
- 003Employer EIN 94-2347624
- Participants (2024)
- 36,458
- Net assets (2024)
- $14.3 billion
- Recordkeeper
- Fidelity2009–2024
- Plan administrator
- Genentech, Inc.
1 Dna Way
South San Francisco, CA 94080
(650) 225-1000As filed for 2024 - In effect since
- October 1, 2012
Plans merged into this one: Genentech, Inc. Tax Reduction Investment Plan (2012); Roche Savings and Pay Deferral Plan (2012); Roche U.S. Retirement Plan (2022); Ventana Medical Systems, Inc. 401(k) Plan (2014); Genmark Diagnostics 401(k) Plan (2022).
Earlier sponsor: Roche Diagnostics Corporation (2009–2011).
Earlier plan names: Roche Diagnostics Corporation Cash Accumulation Plan.
Year by year, 2009 to 2024
| Plan year | Participants | Net assets | Recordkeeper |
|---|---|---|---|
| 2024 | 36,458 | $14.3 billion | Fidelity |
| 2023 | 37,353 | $12.9 billion | Fidelity |
| 2022 | 37,926 | $10.9 billion | Fidelity |
| 2021 | 35,700 | $12.4 billion | Fidelity |
| 2020 | 35,082 | $10.8 billion | Fidelity |
| 2019 | 34,574 | $9.4 billion | Fidelity |
| 2018 | 33,957 | $7.6 billion | Fidelity |
| 2017 | 33,827 | $7.9 billion | Fidelity |
| 2016 | 33,422 | $6.5 billion | Fidelity |
| 2015 | 32,591 | $5.8 billion | Fidelity |
| 2014 | 30,944 | $5.7 billion | Fidelity |
| 2013 | 29,705 | $5.2 billion | Fidelity |
| 2012 | 28,978 | $4.5 billion | Fidelity |
| 2011 | 6,149 | $616 million | Fidelity |
| 2010 | 6,081 | $616 million | Fidelity |
| 2009 | 5,761 | $512 million | Fidelity |